Market Overview:
The global pica eating disorder treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pica eating disorder, rising awareness about available treatments, and growing demand for better-quality healthcare services. The dietary supplements segment is expected to account for the largest share of the global pica eating disorder treatment market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period. The large share of this segment can be attributed to factors such as rising awareness about available treatments and growing demand for better-quality healthcare services. In terms of application, the hospital pharmacies segment is expected to account for the largest share of the global pica eating disorder treatment market in 2018.
Product Definition:
Pica eating disorder is a condition that causes people to eat items that are not food. Pica eating disorder treatment is important because it can help people stop eating non-food items and improve their health.
Dietary Supplements:
Dietary supplements are the nutritional products that are consumed to fulfill the nutrient deficiencies in the human body. The global market for dietary supplements is expected to grow at a lucrative rate over the forecast period owing to factors such as growing health awareness, changing lifestyle of consumers and increasing prevalence of chronic diseases. Increasing demand for nutraceuticals and natural remedies has led many players in this market to develop herbal products along with synthetic vitamins & minerals.
Antipsychotic Drugs:
Antipsychotic drugs are used in the treatment of schizophrenia and other psychotic disorders. They help reduce the hallucinations and false beliefs that are characteristic of these diseases by decreasing activity in areas of the brain that are associated with them. The antipsychotics can be divided into two groups, typical or conventional antipsychotics, and atypical or novel antipsychotics.
Application Insights:
Based on application, the global pica eating disorder treatment market is segmented into hospital pharmacies, retail pharmacies, drug stores and mail order pharmacies. Hospital pharmacy held the largest share of over 60.0% in 2017 owing to availability of a large number of drugs for treating mental disorders in hospitals. Moreover, hospital pharmacists have greater knowledge about medicines as compared to other people due to constant interaction with doctors and patients which helps them in choosing suitable medicines for a particular disease condition.
The retail pharmacy segment is expected to grow at fastest rate during forecast period owing to growing awareness among general public regarding treatment options available for various mental disorders including anxiety and depression through online resources such as Google search engine.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about pica eating disorders and presence of effective treatment methods. Moreover, availability of a wide range of dietary supplements in this region will also help boost revenue growth during the estimated period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population and increasing disposable income among people especially in developing countries such as India, China, Bangladesh & Pakistan etc., which are prone to various nutritional deficiencies including pica eating disorder symptoms (hunger). Moreover, growing medical tourism industry due to low cost treatment options will also drive regional demand further.
Growth Factors:
- Increasing awareness about Pica Eating Disorder Treatment and its symptoms will drive the market growth.
- Rising number of people suffering from Pica Eating Disorder will fuel the demand for Pica Eating Disorder Treatment products and services.
- Growing focus on preventive measures for various eating disorders will create new opportunities for the market growth.
- Technological advancements in the field of Pica Eating Disorder Treatment will offer lucrative opportunities to the market players.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pica Eating Disorder Treatment Market Research Report
By Type
Dietary Supplements, Antipsychotic Drugs, Antidepressants, Mood Stabilizers
By Application
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
By Companies
Novartis International AG, GlaxoSmithKline plc., Merck KGaA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceutical, Torrent Pharmaceuticals Ltd., Micro Labs Limited, FDC Limited, Emcure Pharmaceuticals, Mankind Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Pica Eating Disorder Treatment Market Report Segments:
The global Pica Eating Disorder Treatment market is segmented on the basis of:
Types
Dietary Supplements, Antipsychotic Drugs, Antidepressants, Mood Stabilizers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis International AG
- GlaxoSmithKline plc.
- Merck KGaA
- Sun Pharmaceutical Industries Limited
- Glenmark Pharmaceutical
- Torrent Pharmaceuticals Ltd.
- Micro Labs Limited
- FDC Limited
- Emcure Pharmaceuticals
- Mankind Pharma
Highlights of The Pica Eating Disorder Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dietary Supplements
- Antipsychotic Drugs
- Antidepressants
- Mood Stabilizers
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pica Eating Disorder Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pica is an eating disorder that involves a persistent and abnormal craving for non-food substances, such as dirt, clay, chalk, ice or sand. Pica can be a sign of another mental health condition or it may be caused by a chemical imbalance in the brain. Treatment for pica typically includes medication and therapy.
Some of the major companies in the pica eating disorder treatment market are Novartis International AG, GlaxoSmithKline plc., Merck KGaA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceutical, Torrent Pharmaceuticals Ltd., Micro Labs Limited, FDC Limited, Emcure Pharmaceuticals, Mankind Pharma.
The pica eating disorder treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pica Eating Disorder Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pica Eating Disorder Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pica Eating Disorder Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pica Eating Disorder Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pica Eating Disorder Treatment Market Size & Forecast, 2018-2028
4.5.1 Pica Eating Disorder Treatment Market Size and Y-o-Y Growth
4.5.2 Pica Eating Disorder Treatment Market Absolute $ Opportunity
Chapter 5 Global Pica Eating Disorder Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pica Eating Disorder Treatment Market Size Forecast by Type
5.2.1 Dietary Supplements
5.2.2 Antipsychotic Drugs
5.2.3 Antidepressants
5.2.4 Mood Stabilizers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pica Eating Disorder Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pica Eating Disorder Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Drug Stores
6.2.4 Mail Order Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pica Eating Disorder Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pica Eating Disorder Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pica Eating Disorder Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Pica Eating Disorder Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pica Eating Disorder Treatment Market Size Forecast by Type
9.6.1 Dietary Supplements
9.6.2 Antipsychotic Drugs
9.6.3 Antidepressants
9.6.4 Mood Stabilizers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pica Eating Disorder Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Drug Stores
9.10.4 Mail Order Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pica Eating Disorder Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Pica Eating Disorder Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pica Eating Disorder Treatment Market Size Forecast by Type
10.6.1 Dietary Supplements
10.6.2 Antipsychotic Drugs
10.6.3 Antidepressants
10.6.4 Mood Stabilizers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pica Eating Disorder Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Drug Stores
10.10.4 Mail Order Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pica Eating Disorder Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pica Eating Disorder Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pica Eating Disorder Treatment Market Size Forecast by Type
11.6.1 Dietary Supplements
11.6.2 Antipsychotic Drugs
11.6.3 Antidepressants
11.6.4 Mood Stabilizers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pica Eating Disorder Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Drug Stores
11.10.4 Mail Order Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pica Eating Disorder Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Pica Eating Disorder Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pica Eating Disorder Treatment Market Size Forecast by Type
12.6.1 Dietary Supplements
12.6.2 Antipsychotic Drugs
12.6.3 Antidepressants
12.6.4 Mood Stabilizers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pica Eating Disorder Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Drug Stores
12.10.4 Mail Order Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pica Eating Disorder Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pica Eating Disorder Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pica Eating Disorder Treatment Market Size Forecast by Type
13.6.1 Dietary Supplements
13.6.2 Antipsychotic Drugs
13.6.3 Antidepressants
13.6.4 Mood Stabilizers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pica Eating Disorder Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Drug Stores
13.10.4 Mail Order Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pica Eating Disorder Treatment Market: Competitive Dashboard
14.2 Global Pica Eating Disorder Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis International AG
14.3.2 GlaxoSmithKline plc.
14.3.3 Merck KGaA
14.3.4 Sun Pharmaceutical Industries Limited
14.3.5 Glenmark Pharmaceutical
14.3.6 Torrent Pharmaceuticals Ltd.
14.3.7 Micro Labs Limited
14.3.8 FDC Limited
14.3.9 Emcure Pharmaceuticals
14.3.10 Mankind Pharma
